XB-014

N/A

Report date: 2024/11/15 10:00:02

Base Information

Drug NameXB-014

Drug Alias NameXB-014XB014

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 47 inhibitorsMacrophages stimulantsT lymphocytes stimulants +[4]

TargetsCluster of differentiation 47Programmed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInvenra Inc

China Registration ClassN/A

Develop Information

Active CompaniesExelixis Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A